PA INSIGHTS
Live / Allowed — Notice of allowance issued (as of 30 Sept 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Jun 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98593158
- Mark type
- Stylized text
- Filed
- 10 Jun 2024
- Published for opposition
- 03 Jun 2025
- Attorney of record
- Kevin C. Staed
Goods and services
- Class 035 — Advertising and business services: Business management consulting, strategic planning and business advisory services provided to medical and pharmaceutical industries; Business management of logistics for others; Business management of reimbursement programs for others; Business services provided to a network of health care providers, namely, the negotiation and execution of contracts with health care payors; Consulting services in the field of patient relationship management for healthcare providers; Cost management for the health care benefit plans of others; Cost price analysis; Logistics management in the field of healthcare; Negotiation of business contracts for others; New product commercialization services; Pharmaceutical cost management services and drug utilization review services; Regulatory submission management, namely, assisting others in preparing and filing applications for medical products with governmental regulatory bodies; Business assistance, advisory and consulting services in the field of product distribution, production, operations, logistics, and supply chains; Business assistance, advisory and consulting services in the field of medical product approval; Professional credentialing verification services in the field of healthcare, namely, verifying the skills and knowledge of licensed professionals on behalf of others; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for reviewing pharmacy accreditation and re-accreditation; Software as a service (SAAS) services featuring software for monitoring compliance with pharmacy regulations, requirements, and audits; Software as a service (SAAS) services featuring software for prior authorization initiation, processing, support and analysis; Software as a service (SAAS) services featuring software for prior authorization analysis, namely approval rating, response time, difficulty estimation, workflow predictions, appeal likelihood, appeal outcome estimation, and denial predictions and rationale; Software as a service (SAAS) services featuring software for providing information and actionable intelligence for prior authorizations and providing guidance as to complexity, difficulty in completing, and likelihood for denial during the prior authorization process; Software as a service (SAAS) services featuring software for facilitating the onboarding of patients to new medications, providing ongoing patient education and facilitation of patient compliance to therapy; Software as a service (SAAS) services featuring software using artificial intelligence for prior authorization analysis, namely approval rating, response time, difficulty estimation, workflow predictions, appeal likelihood, appeal outcome estimation, and denial predictions and rationale
Owner
- D2 Pharma Consulting LLC, Chesterfield, MO, US
- D2 Pharma Consulting LLC, Chesterfield, MO, US
Prosecution history
- 07 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 30 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Jan 2025 — NON-FINAL ACTION E-MAILED
- 08 Jan 2025 — NON-FINAL ACTION WRITTEN
- 17 Dec 2024 — ASSIGNED TO EXAMINER
- 14 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Jun 2024 — NEW APPLICATION ENTERED